Vivo Bio Tech allots 2.10 lakh equity shares on conversion of warrants

Image
Capital Market
Last Updated : May 31 2021 | 3:18 PM IST
Vivo Bio Tech has allotted 2,10,000 equity shares of Rs.10/- each at an issue price of Rs.45/-(premium of Rs.35/- each) on conversion of warrants issued on preferential basis to the promoter group on receipt of the balance application money of Rs.70,87,500 /- (being the 75% of the issue price).

Post allotment of the above shares, the paid up equity share capital has increased to Rs 14,20,45,200.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 31 2021 | 2:39 PM IST

Next Story